{
  "docId": "019de070-a7f9-700d-9686-c0d9e2559ea7",
  "docSlug": "49e1302a11c2e640ac427a516c932653",
  "documentTitle": "Bausch Health Companies | Results Presentation Deck | 82 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 23,
  "pageCount": 82,
  "prevPage": 22,
  "nextPage": 24,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "The slide uses trend lines to indicate recovery trajectories for three key pharmaceutical products.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-a7f9-700d-9686-c0d9e2559ea7/23",
  "deckHref": "/decks/019de070-a7f9-700d-9686-c0d9e2559ea7",
  "deckJsonHref": "/decks/019de070-a7f9-700d-9686-c0d9e2559ea7.json",
  "deckAnchorHref": "/decks/019de070-a7f9-700d-9686-c0d9e2559ea7#slide-23",
  "components": [
    {
      "bbox": {
        "h": 0.45,
        "w": 0.3,
        "x": 0.03,
        "y": 0.15
      },
      "kind": "chart",
      "text": "XIFAXAN TRx Trend",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "31cbe9e6-e9c1-4391-9826-a0d821a11956",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.3,
        "x": 0.35,
        "y": 0.15
      },
      "kind": "chart",
      "text": "TRULANCE TRx Trend",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b5a88c19-9164-4310-9e28-b077d4c1eb0c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.3,
        "x": 0.67,
        "y": 0.15
      },
      "kind": "chart",
      "text": "RELISTOR TRx Trend",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cfc38420-d531-44c4-b308-987ea68f526d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.9,
        "x": 0.05,
        "y": 0.68
      },
      "kind": "list",
      "text": "Gastroenterology experienced the second largest decline in patient diagnosis visits in 2020 compared to all other specialties. Recovery in Progress: The number of patient visits with a diagnosis to Gastroenterologists in April 2020 was 48% below pre-COVID levels compared to 15% below in December 2020.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "249cb99f-250e-4cf8-b4cf-c3bb7aebe60c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.25,
        "y": 0.97
      },
      "kind": "source-note",
      "text": "1. IQVIA NPA weekly. 2. IQVIA. Monitoring the Impact of COVID-19 on the Pharmaceutical Market. Published January 15, 2021.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "61ed1954-da40-4c6e-8b55-28638d4be786",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.35,
        "x": 0.05,
        "y": 0.03
      },
      "kind": "title",
      "text": "Salix Recovery Update",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "39ecb2d2-0726-4fe7-aff7-5bdb9820217c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 30,
      "from": 15,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "3f929d33-08a9-4163-8b41-a09e812667a2",
      "evidence": "The presentation emphasizes the importance of execution, growth, and accelerating strategic alternatives.",
      "position": 0,
      "objective": "Highlighting the cost of inaction and the benefits of strategic alternatives",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}